News

Focus on the diagnosis of pathogenic microorganisms in the reproductive tract and respiratory tract

Picture Name

Medomics Medical SARS-CoV-2 Antigen Test Kit has participated in the QCMD EQA Pilot Study initiated by Randox Laboratory in UK with HIGHLY SATISFACTORY result!

2021-11-05 17:00:44

A few days ago, Medomics Medical received the QCMD Global External Quality Assessment report from Randox Laboratory. The report shows that in the QCMD 2021 SARS-CoV-2 Antigen Testing EQA Pilot Study, Medomics Medical successfully passed the evaluation with a "Highly satisfactory" result.

Detection Score: Your detection(qualitative) scores are based on the assigned detection frequency of eachpanel members, where 0 (zero) is "highly satisfactory" and 3 (three)is 

"highly unsatisfactory".

 

Quality Control for Molecular Diagnostics (QCMD) is the world's leading External Quality Assessment (EQA) / Proficiency Testing (PT) organization, dedicated to promoting the quality control of infectious disease molecular diagnostic testing services. Comprehensive project support, complete evaluation system, high-quality testing materials, using inactivated whole pathogens as sample materials, simulating clinical real sample testing to a great extent, QCMD has been recognized by many clinical diagnostic laboratories and testing centers around the world.

 

Your Summary Results :

Individual Panel Member Analysis (Qualitative)

Among the above results, Medomics SARS-CoV-2 Antigen Test Kit performed very well in each sample.

 

The results of the QCMD confirmed once again the excellent quality of SARS-CoV-2 Antigen Test Kit of Medomics Medical. Accurate and reliable testing result, high specification, very trustworthy.

 

Medomics Medical SARS-CoV-2 Antigen Test Kit is certified by ISO 13485, CE, and German BfArM. More rapid tests are for your choice as well, such as Self-Testing SARS-CoV-2 Antigen Test Kit, Neutralizing Antibody Test kits, etc. For more product information, please contact us by info@medomics-dx.com.